SCHEMBL470287

SCHEMBL470287

Cc1cc(-c2cnc3c(NCC4CNC4)cc(-c4ccccc4CO)nn23)ccc1C(=O)NC1CC1

nearest known ligand 0.57

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTK P33981 20/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL456217 0.91 TTK (0.69) TTK
SCHEMBL469950 0.90 TTK (0.58) TTK
SCHEMBL456420 0.90 TTK (0.64) TTK
SCHEMBL10279522 0.89 TTK (0.54) TTK
SCHEMBL469958 0.88 TTK (0.58) TTK
SCHEMBL457649 0.88 TTK (0.66) TTK
SCHEMBL455773 0.88 TTK (0.54) TTK
SCHEMBL15555228 0.88 TTK (0.53) TTK
SCHEMBL457781 0.87 TTK (0.53) TTK
SCHEMBL469945 0.86 TTK (0.54) TTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014020041-A1 COMBINATIONS FOR THE TREATMENT OF CANCER BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-02-06 WO claimed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
EP-2614063-B1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER IP GMBH (DE) 2016-01-13 EP disclosed
WO-2012032031-A1 SUBSTITUTED IMIDAZOPYRIDAZINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-03-15 WO disclosed